Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
24 Outubro 2023 - 9:00AM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,
diversified specialty pharmaceutical company committed to improving
the lives of people living with serious medical conditions, today
announced that it will report third quarter 2023 financial results
after the market closes on Tuesday, November 7, 2023.
Following the release of the financials, the Company will host a
live conference call and webcast at 4:30 p.m. ET.
Conference Call Information To access the
conference call, please dial (877) 407-8037 (U.S.) or (201)
689-8037 (International) and reference the “Collegium
Pharmaceutical Q3 2023 Earnings Call.” An audio webcast will be
accessible from the Investors section of the Company’s
website: www.collegiumpharma.com. The webcast will be
available for replay on the Company’s website approximately two
hours after the event.
About Collegium Pharmaceutical,
Inc.Collegium is a leading, diversified specialty
pharmaceutical company committed to improving the lives of people
living with serious medical conditions. Collegium’s headquarters
are located in Stoughton, Massachusetts. For more information,
please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher James, M.D.Vice
President, Investor Relationsir@collegiumpharma.com
Media Contact:Marissa SamuelsVice President,
Corporate Communicationscommunications@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024